Clinical trial NCT07014358: Clinical Trial to Evaluate Three Systems of Osteosynthesis for Fixation of Olecranon Osteotomies in Adults
Official title: Randomized, Patient-blinded, Evaluator-blinded Clinical Trial With Three CE-marked and Approved Devices
Study type: INTERVENTIONAL
Overall status: NOT_YET_RECRUITING
Phase: PHASE4
Conditions: Olecranon Fracture
Lead sponsor: Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
Sponsor class: OTHER
First posted: 2025-06-11
Enrollment: 105
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: Surgery of the elbow joint is often made difficult by the highly constrained nature of the elbow joint. This is why it is often necessary to perform an osteotomy of the olecranon, the proximal part of the ulna, which allows perfect exposure of the entire articular surface. After performing the osteotomy, access to the joint is obtained, the articular problem is solved as appropriate and, upon completion, the osteotomized bone is fixed with a stable fixation system that allows the osteotomy to heal without problems. It is a safe, reproducible procedure that is associated with low associated morbidity. The main problems associated with this procedure are the lack of consolidation of the osteotomy or the need for removal of the osteosynthesis material at a later stage.

Detailed description: The incidence of these complications is around 4% for the former and 20-50% for the latter. Both complications usually require a second surgical procedure to solve the problem, so the reoperation rates for these procedures are around 40-50%.

However, there is discussion in the literature as to the most appropriate fixation system to ensure fracture healing. There are, broadly speaking, three frequently used fixation systems: the placement of two steel pins and a wire in an obenque configuration, the placement of a screwed plate or the placement of a compression screw.

It is not clear which is the best fixation system among these three. Biomechanical studies suggest that, from this point of view, all three procedures are adequate. The choice of which is ideal should therefore be based on the ease of use and the complications associated with the procedure, in particular the reoperation rate.There are no clinical trials in the literature comparing these three fixation techniques, so there is a clear lack of knowledge in this field.

Eligibility criteria: Inclusion Criteria:

* Patients who, after receiving information about the design, the purposes of the study, the possible risks that may arise from it and the fact that they may refuse to collaborate at any time, give their written consent to participate in the study.
* Be over 18 years of ag
* Have an elbow disorder that is to be treated surgically through an olecranon osteotomy approach.
* That the olecranon osteotomy is amenable to synthesization with the three proposed systems.
* Understand the purpose of the study and be available for routine hospital visits.

Exclusion Criteria:

* Patients who have undergone ipsilateral elbow surgery.
* Presence of ulnar fractures
* Patients with an active infection at any site at the time of elbow surgery.
* Inability to understand the procedure or information related to the study.

Primary outcomes:
measure: Define which of the three fixarion systems is safer based on the number of patients with each fixation system that need to be reintervened.
timeFrame: 12 Months
Secondary outcomes:
measure: Number of patients suffering Adverse Events related or not with the medical product within a year
timeFrame: 12 months
measure: Number of patients suffering Adverse Events related or not with the medical product within a year
timeFrame: 12 months
measure: Number of patients suffering: Adverse Events related or not with the medical product within a year
timeFrame: 12 months
measure: Number of patients suffering Adverse Events related or not with the medical product, within a year
timeFrame: 12 months
measure: Number of patients suffering Adverse Events, related or not with the medical product, within a year
timeFrame: 12 months
measure: Number of patients suffering Adverse Events related or not, with the medical product, within a year
timeFrame: 12 months
measure: Efficacy measured usimg the evaluation of different scales and tests performed by the patient, that altogether provide the needed information about the efficacy of the medical product.
timeFrame: 24 months
measure: Efficacy, measured usimg the evaluation of different scales and tests performed by the patient that altogether provide the needed information about the efficacy of the medical product.
timeFrame: 24 months
measure: Efficacy, measured usimg the evaluation of different scales and tests performed by the patient, that altogether provide the needed information about the efficacy of the medical product
timeFrame: 24 months
Other outcomes:
Locations:
city: Santander
country: Spain
facility: Hospital Mutua Montañesa Santander
state: Cantabria
city: Madrid
country: Spain
facility: Clínica CEMTRO
state: Comunidad De Madrid
city: Valencia
country: Spain
facility: Hospital La Fe
state: Comunidad Valenciana
city: Valencia
country: Spain
facility: Hospital de Manises
state: Manises
city: Madrid
country: Spain
facility: Hospital Universitario de Móstoles
Study officials:
References: